US Patent 9834789 Recombinant adeno-associated vectors for targeted treatment
Patent 9834789 was granted and assigned to City of Hope on December, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 21, 2017
Date of Patent
December 5, 2017
Patent Applicant
Patent Application Number
15465387
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9834789 Recombinant adeno-associated vectors for targeted treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.